Answers are grounded in this paper and cite their sources.
In this report we present a polyketal, termed pADK, which has adamantane groups embedded in its backbone, and degrades into neutral excretable compounds. pADK was synthesized via click chemistry and had a MW of 49 472 and a PDI of 1.74. We demonstrate here that pADK can increase the transfection efficiency of CD1800 (PEI of 1800 modified β-cyclodextrin) 60 fold, yet cause no increase in toxicity.
No takes yet. Share an insight, caveat, or question.
Maity et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: